First Time Loading...

Immunoprecise Antibodies Ltd
XTSX:IPA

Watchlist Manager
Immunoprecise Antibodies Ltd Logo
Immunoprecise Antibodies Ltd
XTSX:IPA
Watchlist
Price: 6.5 CAD 0.78%
Updated: May 9, 2024

Immunoprecise Antibodies Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immunoprecise Antibodies Ltd
Research & Development Peer Comparison

Comparables:
ABCL
ARCH
RP
IOT

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Immunoprecise Antibodies Ltd
XTSX:IPA
Research & Development
-CA$2m
CAGR 3-Years
-57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abcellera Biologics Inc
NASDAQ:ABCL
Research & Development
-$175.7m
CAGR 3-Years
-81%
CAGR 5-Years
-98%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Research & Development
-CA$5.5m
CAGR 3-Years
N/A
CAGR 5-Years
-26%
CAGR 10-Years
-64%
Replicel Life Sciences Inc
XTSX:RP
Research & Development
-CA$514.3k
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
7%
Innovotech Inc
XTSX:IOT
Research & Development
-CA$186k
CAGR 3-Years
-57%
CAGR 5-Years
-37%
CAGR 10-Years
11%

See Also

What is Immunoprecise Antibodies Ltd's Research & Development?
Research & Development
-2m CAD

Based on the financial report for Apr 30, 2021, Immunoprecise Antibodies Ltd's Research & Development amounts to -2m CAD.

What is Immunoprecise Antibodies Ltd's Research & Development growth rate?
Research & Development CAGR 3Y
-57%

Over the last year, the Research & Development growth was -338%. The average annual Research & Development growth rates for Immunoprecise Antibodies Ltd have been -57% over the past three years .